Abnormal Pulmonary Function in Adults with Sickle Cell Anemia

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2006 Mar 25

PMID 16556694

Citations 74

Authors

Elizabeth S Klings

Diego F Wyszynski

Vikki G Nolan

Martin H Steinberg

Affiliations

Soon will be listed here.

Abstract

Rationale: Pulmonary complications of sickle cell anemia (Hb-SS) commonly cause morbidity, yet few large studies of pulmonary function tests (PFTs) in this population have been reported.

Objectives: PFTs (spirometry, lung volumes, and diffusion capacity for carbon monoxide [DLCO]) from 310 adults with Hb-SS were analyzed to determine the pattern of pulmonary dysfunction and their association with other systemic complications of sickle cell disease.

Methods: Raw PFT data were compared with predicted values. Each subject was subclassified into one of five groups: obstructive physiology, restrictive physiology, mixed obstructive/restrictive physiology, isolated low DLCO, or normal. The association between laboratory data of patients with decreased DLCO or restrictive physiology and those of normal subjects was assessed by multivariate linear regression.

Measurements And Main Results: Normal PFTs were present in only 31 of 310 (10%) patients. Overall, adults with Hb-SS were characterized by decreased total lung capacities (70.2 +/- 14.7% predicted) and DLCO (64.5 +/- 19.9%). The most common PFT patterns were restrictive physiology (74%) and isolated low DLCO (13%). Decreased DLCO was associated with thrombocytosis (p = 0.05), with hepatic dysfunction (elevated alanine aminotransferase; p = 0.07), and a trend toward renal dysfunction (elevated blood urea nitrogen and creatinine; p = 0.05 and 0.07, respectively).

Conclusions: Pulmonary function is abnormal in 90% of adult patients with Hb-SS. Common abnormalities include restrictive physiology and decreased DLCO. Decreased DLCO may indicate more severe sickle vasculopathy characterized by impaired hepatic and renal function.

Citing Articles

Pulmonary Function after Nonmyeloablative Hematopoietic Cell Transplant for Sickle Cell Disease.

Ruhl A, Shalhoub R, Jeffries N, Limerick E, Leonard A, Barochia A Ann Am Thorac Soc. 2024; 21(10):1398-1406.

PMID: 39189784 PMC: 11451896. DOI: 10.1513/AnnalsATS.202309-771OC.

A Rare Case of Multiple Bone Infarctions and Abnormal Pulmonary Function Tests in a Patient With Compound Heterozygous Hemoglobin S and Type 2 Hereditary Persistence of Fetal Hemoglobin.

Alnaqbi K Cureus. 2024; 16(8):e66395.

PMID: 39113817 PMC: 11305617. DOI: 10.7759/cureus.66395.

Risk factors associated with in-hospital complications for pediatric sickle-cell disease-associated moyamoya syndrome: a nationwide cross-sectional study.

Osorio R, Raygor K, Rinaldo L, Fox C, Bhasin N, Abla A Childs Nerv Syst. 2024; 40(7):2109-2114.

PMID: 38530413 DOI: 10.1007/s00381-024-06363-2.

Aerobic physical capacity and health-related quality of life in children with sickle cell disease.

Laurent-Lacroix C, Vincenti M, Matecki S, Mahe P, Moulis L, De La Villeon G Pediatr Res. 2024; 96(4):1006-1012.

PMID: 38491141 DOI: 10.1038/s41390-024-03143-1.

Sterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease.

Rarick K, Li K, Teng R, Jing X, Martin D, Xu H Free Radic Biol Med. 2024; 215:112-126.

PMID: 38336101 PMC: 11290318. DOI: 10.1016/j.freeradbiomed.2024.01.052.

References

Crapo R, Morris A . Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis. 1981; 123(2):185-9. DOI: 10.1164/arrd.1981.123.2.185. View

Miller G, Serjeant G . An assessment of lung volumes and gas transfer in sickle-cell anaemia. Thorax. 1971; 26(3):309-15. PMC: 1019088. DOI: 10.1136/thx.26.3.309. View

Gaston M, Rosse W . The cooperative study of sickle cell disease: review of study design and objectives. Am J Pediatr Hematol Oncol. 1982; 4(2):197-201. View

POWARS D, Weidman J, Niland J, JOHNSON C . Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore). 1988; 67(1):66-76. View

Gaston M, Smith J, Gallagher D, West S, Bellevue R, Farber M . Recruitment in the Cooperative Study of Sickle Cell Disease (CSSCD). Control Clin Trials. 1987; 8(4 Suppl):131S-140S. DOI: 10.1016/0197-2456(87)90016-x. View

Eaton W, Hofrichter J . Sickle cell hemoglobin polymerization. Adv Protein Chem. 1990; 40:63-279. DOI: 10.1016/s0065-3233(08)60287-9. View

DAlonzo G, Barst R, Ayres S, Bergofsky E, Brundage B, Detre K . Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991; 115(5):343-9. DOI: 10.7326/0003-4819-115-5-343. View

Roberts C, MacRae K, Winning A, Adams L, Seed W . Reference values and prediction equations for normal lung function in a non-smoking white urban population. Thorax. 1991; 46(9):643-50. PMC: 463354. DOI: 10.1136/thx.46.9.643. View

. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991; 144(5):1202-18. DOI: 10.1164/ajrccm/144.5.1202. View

10.

Akinola N, Stevens S, Franklin I, Nash G, Stuart J . Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol. 1992; 45(10):902-6. PMC: 495063. DOI: 10.1136/jcp.45.10.902. View

11.

Platt O, Brambilla D, Rosse W, Milner P, Castro O, Steinberg M . Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994; 330(23):1639-44. DOI: 10.1056/NEJM199406093302303. View

12.

Guasch A, Cua M, Mitch W . Early detection and the course of glomerular injury in patients with sickle cell anemia. Kidney Int. 1996; 49(3):786-91. DOI: 10.1038/ki.1996.109. View

13.

Marrades R, Diaz O, Roca J, Campistol J, Torregrosa J, Barbera J . Adjustment of DLCO for hemoglobin concentration. Am J Respir Crit Care Med. 1997; 155(1):236-41. DOI: 10.1164/ajrccm.155.1.9001318. View

14.

Leong M, Dampier C, Varlotta L, Allen J . Airway hyperreactivity in children with sickle cell disease. J Pediatr. 1997; 131(2):278-83. DOI: 10.1016/s0022-3476(97)70166-5. View

15.

Leong C, Stark P . Thoracic manifestations of sickle cell disease. J Thorac Imaging. 1998; 13(2):128-34. DOI: 10.1097/00005382-199804000-00008. View

16.

Santoli F, Zerah F, Vasile N, Bachir D, Galacteros F, Atlan G . Pulmonary function in sickle cell disease with or without acute chest syndrome. Eur Respir J. 1998; 12(5):1124-9. DOI: 10.1183/09031936.98.12051124. View

17.

Aaron S, Dales R, Cardinal P . How accurate is spirometry at predicting restrictive pulmonary impairment?. Chest. 1999; 115(3):869-73. DOI: 10.1378/chest.115.3.869. View

18.

Knight-Madden J, Forrester T, Lewis N, Greenough A . Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax. 2005; 60(3):206-10. PMC: 1747351. DOI: 10.1136/thx.2004.029165. View

19.

Machado R, Gladwin M . Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol. 2005; 129(4):449-64. DOI: 10.1111/j.1365-2141.2005.05432.x. View

20.

Steinberg M . Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005; 129(4):465-81. DOI: 10.1111/j.1365-2141.2005.05411.x. View